STOCK TITAN

Waters Stock Price, News & Analysis

WAT NYSE

Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.

Waters Corporation (NYSE: WAT) is a global company in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences. This news page aggregates announcements, press releases, and corporate updates related to Waters, giving readers a focused view of developments that affect the company and its markets.

Investors and industry professionals can use this feed to follow Waters’ product launches, financial results, and strategic initiatives. Recent news has highlighted new technologies such as the Xevo Charge Detection Mass Spectrometer (CDMS), which Waters describes as enabling direct mass detection for large biomolecules relevant to next-generation therapeutics, and a Charged Aerosol Detector designed for use with the company’s Empower chromatography data system. These announcements illustrate how Waters is addressing analytical challenges in pharmaceuticals, biotherapeutics, food analysis, and environmental testing.

The news stream also features quarterly earnings releases, where Waters reports sales performance, instrument and recurring revenue trends, and commentary from management. In addition, Waters issues updates on investor conference presentations and on the planned combination with BD’s Biosciences & Diagnostic Solutions business via a Reverse Morris Trust transaction, as described in its press releases and Form 8-K filings.

By reviewing Waters-related news in one place, readers can track themes such as instrument replacement cycles, adoption of new chromatography and mass spectrometry products, and the company’s expansion into adjacencies like bioseparations, bioanalytical characterization, and multiplex diagnostics. Bookmark this page to monitor ongoing disclosures and media releases that shape the narrative around WAT stock and Waters’ role in regulated, high-volume testing and scientific markets.

Rhea-AI Summary

Waters Corporation (NYSE:WAT) announced the launch of its ACQUITY™ PREMIER Columns, featuring MaxPeak™ High Performance Surface (HPS) technology. These premium sub-2-micron columns significantly enhance data quality by reducing sample analyte loss due to adsorption. Designed for comprehensive use with UHPLC systems, these columns improve sample throughput and assay reproducibility, addressing a critical challenge in analytic laboratories. The product aims to bolster analytical confidence across various applications, including small molecules and biopharmaceuticals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.97%
Tags
-
Rhea-AI Summary

Waters Corporation (NYSE:WAT) will host a live webcast of its Q3 2020 financial results conference call on October 27 at 8:00 a.m. ET. Investors can access the call through Waters' website, with a replay available until November 3. Waters is a leader in specialty measurement technologies, focusing on chromatography, mass spectrometry, and thermal analysis across various sectors including life and materials sciences. The company operates in 35 countries with over 7,000 employees and has a significant global presence, featuring 15 manufacturing facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags

FAQ

What is the current stock price of Waters (WAT)?

The current stock price of Waters (WAT) is $301.88 as of May 4, 2026.

What is the market cap of Waters (WAT)?

The market cap of Waters (WAT) is approximately 30.1B.